发明名称 |
ANTI-IL12RBETA1 ANTIBODIES AND THEIR USE IN TREATING AUTOIMMUNE AND INFLAMMATORY DISORDERS |
摘要 |
<p>The present invention relates to antibodies that specifically bind to IL12Rβ1, the non-signal transducing chain of both the heterodimeric IL12 and IL23 receptors. The invention more specifically relates to specific antibodies that are IL12 and IL23 receptor antagonists capable of inhibiting IL12/IL18 induced IFNγproduction of blood cells and compositions and methods of use for said antibodies to treat pathological disorders that can be treated by inhibiting IFNγproduction, IL12 and/IL23 signaling, such as rheumatoid arthritis, psoriasis or inflammatory bowel diseases or other autoimmune and inflammatory disorders.</p> |
申请公布号 |
EP2625203(A1) |
申请公布日期 |
2013.08.14 |
申请号 |
EP20110766979 |
申请日期 |
2011.10.03 |
申请人 |
NOVARTIS AG |
发明人 |
CARBALLIDO HERRERA, JOSE M.;HARTLE, STEFAN;HEUSSER, CHRISTOPH;KLAGGE, INGO;POLZER, ANDREA;SCHWAERZLER, CHRISTOPH;WOCHNIK-VELTRUP, GABRIELA |
分类号 |
C07K16/28 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|